SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
Nome Químico: N-(2,4 Dimethylphenyl)-1-Butylpiperidine-2-carboxamide
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Sorrisos: O=C(C1N(CCCC)CCCC1)NC2=CC=C(C)C=C2C
Bupivacaine Impurity 4 is chemically N-(2,4 Dimethylphenyl)-1-Butylpiperidine-2-carboxamide. Bupivacaine Impurity 4 is supplied with detailed characterization data compliant with regulatory guideline. Bupivacaine Impurity 4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Bupivacaine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Simultaneous determination of bupivacaine, mepivacain, prilocaine and ropivacain in human serum by liquid chromatography–tandem mass spectrometry
A. Koehler ∗, R. Oertel, W. Kirch
Journal of Chromatography A, 1088 (2005) 126–130
Racemisation of R-Bupivacaine: A Key Factor in the Integrated and Economic Process for the Production of Levobupivacaine
Marianne Langston,* Ulrich C. Dyer,† Graham A. C. Frampton, Gordon Hutton,‡ Christopher J. Lock, Benjamin M. Skead, Martin Woods,§ and Hooshang S. Zavareh
Organic Process Research & Development 2000, 4, 530−533
Investigation into spinal anesthetic failure with hyperbaric bupivacaine: the role of cold exposure on bupivacaine degradation
Ellen K. Wasan PhD, Calen Sacevich MD, Anas El-Aneed PhD, Munawar Mohammed MSc, Jaweria Syeda MPharm, Erin Neville BSP, Tatiana Orlowski, David Campbell MD & Jonathan Gamble MD
Canadian Journal of Anesthesia/Journal canadien d'anesthésie volume 66, pages803–812(2019)